Thank you for your interest in a new study being conducted by RDC Clinical in partnership with UQ which is evaluating the effectiveness of orally-dosed curcumin, on increasing brain-derived neurotrophic factor (BDNF). BDNF is a neurotrophin essential for neuronal development and survival. It helps to regulate synaptic plasticity which is important for cognitive function, including learning and memory. BDNF may also protect against neurodegenerative disease such as Alzheimer’s and Parkinson’s.
To help with this study, we’re looking for healthy adults aged 18-40 years who are living in Brisbane (or surrounds).
How long is the study, and when does it start?
Participation in this study will last for 6 weeks. During this time, you’ll be asked to attend our clinic in Newstead, Brisbane, on 3 occasions to complete a questionnaire about your health, have some measurements taken (such as height, weight and blood pressure), and have a blood test done. You will be given the study product in capsule form to take once daily for the duration of the study. To make the timings of these visits as convenient as possible to you, we are recruiting on a rolling basis which means that the start date is flexible.
The timings of assessments are:
- Your initial assessment at a date convenient to you (we are open Monday-Saturday)
- Your midpoint assessment approximately 3 weeks after your initial visit
- Your final assessment approximately 6 weeks after your initial visit
If you’re interested in taking part, we’d love your help. Please see below for more information. The eligibility & registration form is at the bottom of the page.